Flizasertib is a serine/threonine kinase inhibitor that acts by inhibiting RIPK1 (Receptor-interacting serine/threonine-protein kinase 1 ), which has anti-inflammatory and therapeutic effects on immune disorders.
Molecular Weight:
271.29
Purity:
>99.99%
CAS Number:
[2268739-68-8]
Formula:
C15H14FN3O
Target:
RIP kinase|||Serine Protease
T69711
* VAT and and shipping costs not included. Errors and price changes excepted